|Institutional Source||Beutler Lab|
|Gene Name||malic enzyme 2, NAD(+)-dependent, mitochondrial|
|Is this an essential gene?||Non essential (E-score: 0.000)|
|Stock #||R3422 (G1)|
|Chromosomal Location||73770040-73815392 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||C to T at 73791194 bp|
|Amino Acid Change||Alanine to Threonine at position 316 (A316T)|
|Ref Sequence||ENSEMBL: ENSMUSP00000025439 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000025439]|
|Predicted Effect||probably damaging
AA Change: A316T
PolyPhen 2 Score 0.990 (Sensitivity: 0.72; Specificity: 0.97)
AA Change: A316T
|Meta Mutation Damage Score||0.7325|
|Coding Region Coverage||
|Validation Efficiency||100% (40/40)|
|MGI Phenotype||FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a mitochondrial NAD-dependent malic enzyme, a homotetrameric protein, that catalyzes the oxidative decarboxylation of malate to pyruvate. It had previously been weakly linked to a syndrome known as Friedreich ataxia that has since been shown to be the result of mutation in a completely different gene. Certain single-nucleotide polymorphism haplotypes of this gene have been shown to increase the risk for idiopathic generalized epilepsy. Alternatively spliced transcript variants encoding different isoforms found for this gene. [provided by RefSeq, Dec 2009]|
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Me2||
(F):5'- GTGCTGTCAATGCCCAACTC -3'
(R):5'- TATTTCTTGGAGCAGGAGAAGTAAG -3'
(F):5'- TGTCAATGCCCAACTCCAACAC -3'
(R):5'- CCTGGACTACATAGTGAGTTCCAG -3'